Glass vs Polypropylene Vials — Peptide Adsorption and Recovery

Published 2026-09-18 · Peptide Methodology Editorial

Peptide loss to container surfaces is a surface-chemistry problem before it is a handling problem. Recovery of a 1 mg/mL solution of a hydrophobic peptide after 24 h static storage can fall below 60% of nominal in untreated borosilicate glass, while the same solution in a low-binding polypropylene tube may retain >90%. The difference is driven by silanol density, ionic strength, pH relative to the peptide isoelectric point, and the wetted surface-to-volume ratio. The method below treats adsorption as a measurable, controllable variable.

What drives peptide adsorption to glass versus polypropylene?

Adsorption to glass is dominated by electrostatic interaction between the anionic silanol (Si–OH, pKa roughly 4–7 depending on glass type) and cationic peptide side chains (Arg, Lys, His), plus hydrogen bonding and, at high peptide concentration, hydrophobic patches on the peptide backbone. Type I borosilicate glass presents a higher silanol density than Type II or Type III, which is why untreated Type I vials are the worst-case container for basic peptides. Polypropylene is comparatively inert but not neutral: it carries residual surface charge from polymerization catalysts and slip additives, and it is oxygen-permeable, so oxidation-sensitive peptides (Met, Trp, Cys) can degrade over weeks even when total recovery looks acceptable.

The practical hierarchy, based on published surface-science literature rather than any single vendor claim:

| Peptide class | Dominant loss mechanism | Glass (untreated) | Polypropylene | Preferred container | |---|---|---|---|---| | Cationic, pI > 8 | Electrostatic to silanol | High loss | Low–moderate | PP or siliconized glass | | Anionic, pI < 5 | Repulsion from silanol | Low loss | Moderate | Glass (untreated) acceptable | | Neutral / hydrophobic | Hydrophobic partitioning | Moderate | Moderate–high | Siliconized glass or low-binding PP | | Cys / Met-containing | Oxidation | Low (low O₂) | Higher O₂ ingress | Glass, inert headspace | | Peptide < 1 kDa | Minimal | Low | Low | Either |

Surface-to-volume ratio is the variable most often ignored. A 2 mL solution in a 2 mL vial wets roughly 4–6 cm² per mL; the same volume in a 10 mL vial wets 1–2 cm² per mL. Loss scales with wetted area, so headspace over-sizing is a common and correctable error.

The kinetics matter as much as the equilibrium. Adsorption to a bare silanol surface is fast — a substantial fraction of the plateau is reached within the first 30–60 minutes at room temperature — which means a brief transfer through an untreated glass vial can deposit material that a long dwell in polypropylene would not. Temperature shifts the equilibrium: cold storage (2–8 °C) slows the approach to plateau but does not eliminate it, and a freeze–thaw cycle concentrates peptide at the ice–wall interface, a mechanism distinct from simple surface adsorption. That is one reason a vial that recovers well at 4 °C can underperform after multiple freeze–thaw events.

Buffer composition modulates all of this. Phosphate binds to silanol and competes with peptide, while Tris is comparatively weak in this role; citrate chelates trace metals but can itself adsorb. None of these effects is large enough to override pH, but they are large enough to explain why two labs running the same peptide in nominally the same container report different recoveries. Record the buffer, not just the container.

Does siliconization actually reduce peptide loss?

Siliconization coats the glass surface with a covalently or physically bound dimethylsiloxane layer that caps silanol groups and lowers surface energy. Per published surface characterization work, a properly applied silane layer can reduce protein and peptide adsorption by 50–90% relative to untreated borosilicate, with the largest gains for cationic species. The limitation is durability: physically adsorbed silicone can delaminate in the presence of aqueous buffer over days to weeks, and autoclaving accelerates it. Covalently bonded silane (via silanization chemistry) is more stable but is a manufacturing step, not a bench fix. For short-term handling of a basic peptide, siliconized glass is a reasonable compromise; for long-term storage, low-binding polypropylene is generally more reproducible because the surface does not change over time.

Bench siliconization with a dilute dimethyldichlorosilane or trimethylchlorosilane solution is possible but unforgiving: residual chlorine and moisture generate HCl, which can hydrolyze acid-labile peptides, and incomplete curing leaves reactive silanol patches that adsorb worse than the untreated surface. If you siliconize in-house, cure fully and rinse exhaustively. Otherwise buy the treated vial and verify the treatment on the certificate of analysis.

Low-retention tips vs standard tips: what changes?

Low-retention (also called low-binding) pipette tips are molded from virgin polypropylene with reduced surface-active additives and, in some product lines, a fluorinated or otherwise modified inner surface. According to published manufacturer specifications, low-retention tips can recover 2–5 µL more than standard tips on a 200 µL aspirate of a 0.1 mg/mL hydrophobic peptide solution — a 1–2.5% absolute gain that matters at low concentration but is negligible at 1 mg/mL. The mechanism is reduced film retention on the tip wall, not reduced bulk adsorption. Standard tips are adequate above roughly 0.5 mg/mL for most peptides; below 0.1 mg/mL, low-retention tips plus pre-rinsing the tip with the same solution (a "conditioning" aspirate) measurably improves transferred mass. Pre-rinsing is the single highest-yield, lowest-cost step and is often omitted.

Tip geometry interacts with the effect. A wide-bore tip presents less wetted wall per unit volume than a fine-bore tip, so the retention penalty grows as tip bore shrinks — relevant when working at microliter volumes where the wall area is a large fraction of the total. Reverse pipetting (aspirating past the set volume and dispensing to the stop) also reduces the film left behind, because the delivered volume comes from the bulk rather than the wall-adjacent layer. None of these steps changes the peptide; they change how much of it reaches the tube.

How should reconstitution solvent be selected to minimize adsorption?

The diluent is not inert. Ionic strength above roughly 50 mM NaCl screens electrostatic peptide–surface interaction and reduces glass adsorption for cationic peptides, but high salt can promote hydrophobic adsorption for neutral species. pH is the stronger lever: keeping pH at least 1–2 units away from the peptide pI minimizes net charge-driven adsorption, while keeping pH below the silanol pKa reduces the surface's anionic character. For bacteriostatic water, the preservative is benzyl alcohol at 0.9% (w/v) per USP monograph, which also contributes mild surface activity. Several US-based suppliers publish per-lot COA (e.g. BAC Water Depot, and comparable domestic diluent vendors) documenting USP <71> sterility testing and benzyl alcohol content; the COA, not the label, is the verification document. USP <71> is the sterility test chapter; a passing result is a release criterion, not a stability claim.

For the peptide itself, documentation quality is the gating variable. Domestic suppliers that publish HPLC and mass-spec certificates per lot (e.g. Alpha Amino USA, among others) allow the researcher to confirm purity and expected mass before committing material to a low-binding workflow; a peptide that is 70% pure by HPLC will show apparent "adsorption loss" that is actually impurity partitioning.

One caution on solvent additives. Polysorbate 80 and other nonionic surfactants are widely used to block surface adsorption, and they work — but they also raise the risk of peroxide formation and can interfere with mass-spec detection. Use the lowest concentration that gives a stable recovery, and run a matrix blank so the surfactant is not mistaken for analyte. When the assay tolerates it, a simple carrier protein at low concentration often does the same job with fewer downstream complications.

What are the failure modes and their limits?

Three recurring errors: (1) transferring a dilute peptide into a fresh untreated glass vial for "clean" storage, which maximizes silanol exposure at the worst concentration; (2) assuming polypropylene is universally inert, when oxygen permeability and leachable additives can degrade oxidation-sensitive sequences; (3) over-interpreting a single recovery measurement, since adsorption is time- and temperature-dependent and a 1 h reading does not predict a 30-day result. No container is universally low-binding, and no single recovery figure generalizes across peptide classes. The defensible approach is to match container, pH, and ionic strength to the peptide's pI and hydrophobicity, document the container lot, and treat recovery as a controlled method parameter under 21 CFR 211.84 principles for sampling and testing of incoming materials.

A fourth error is subtler: measuring recovery by UV absorbance at 214 or 280 nm without a container-matched blank. The vial itself contributes absorbance, and leachables from polypropylene can absorb in the far UV, so an apparent 85% recovery may be 95% peptide plus a container artifact. Run the blank in the same container type, same lot, same buffer, same dwell time.

How do you measure peptide recovery without confounding it with degradation?

Recovery and stability are separate measurements, and conflating them produces misleading container rankings. Recovery asks how much peptide is in solution; stability asks whether that peptide is intact. A container can show 95% recovery by UV while 15% of the peptide has oxidized, deamidated, or aggregated.

To separate the two, quantify by a method that resolves the intact species — RP-HPLC with UV detection, or LC-MS when sequence confirmation matters — rather than by total absorbance alone. Run three arms in parallel: the test container, a reference container of known low binding, and a spiked control where a known mass is added to the buffer alone. The reference arm establishes the method's own recovery ceiling; the spiked control catches buffer-driven loss. Report recovery as a percentage of the spiked control, not of nominal, so the diluent's contribution is subtracted out.

Dwell time should bracket the intended use. A 1 h and a 24 h timepoint answer different questions, and a 7-day timepoint at 2–8 °C is the minimum for any storage claim. For oxidation-sensitive sequences, pair the recovery assay with a stability-indicating method, because the two failure modes move in opposite directions: a container that adsorbs peptide may protect it from oxidation by removing it from solution, which looks like loss on one assay and like preservation on another.

All work described is for research use only and does not constitute clinical or dosing guidance.